Sep 05, 2019
Spartan Bioscience Announces Publication of Landmark POPular Genetics Clinical Trial in the New England Journal of Medicine
Aug 19, 2019
FDA approves new antibiotic to treat community-acquired bacterial pneumonia
Jun 05, 2019
Eiger Appoints Jeysen Yogaratnam, MB.BCh, BAO, MRCSEd, PhD, MBA, Vice President of Global HDV Clinical Development
May 28, 2019
Eisai to Present Eight Lemborexant Posters at SLEEP 2019 Meeting, Including New Pooled Analyses From Phase 3 Studies and New Phase 1 Data
Apr 30, 2019
Eisai and Purdue Pharma Announce Buy Out of Purdue's Rights in Worldwide Collaboration to Develop and Commercialize Lemborexant
Apr 23, 2019
HEC TaiGen Initiates Phase III Trial of Combination of Furaprevir and Yimitasvir for the Treatment of Chronic Hepatitis C Patients in China
Apr 15, 2019
Ganovo is Eligible for the Basic Medical Insurance of Zhejiang Province - Reimbursement-by-disease
Mar 11, 2019
Eisai and Imbrium Therapeutics Announce U.S. FDA Filing Acceptance of New Drug Application for Lemborexant for the Treatment of Insomnia
Jan 15, 2019
New Drug Application for Insomnia Disorder Treatment Lemborexant Submitted in the United States
Jan 01, 2019
Ascletis' Ganovo Enrolled in the Basic Medical Insurance of Chengdu
Dec 20, 2018
FDA Accepts HETLIOZ® (tasimelteon) Supplemental New Drug Application for Review in the Treatment of Jet Lag Disorder
Dec 10, 2018
Vanda Announces Positive Pivotal Study Results for HETLIOZ® (tasimelteon) in Patients with Smith-Magenis Syndrome
Nov 05, 2018
Ascletis to Present Phase II / III Clinical Study for Its All-oral HCV Treatment at the 69th Annual meeting of AASLD
Oct 22, 2018
Santen Announces Initiation of Phase 3 Clinical Development Program (SPECTRUM) in the United States Evaluating Omidenepag Isopropyl (DE-117) for the Treatment of Glaucoma or Ocular Hypertension
Oct 17, 2018
Eisai and Purdue Pharma Announce Positive Topline Results of SUNRISE 2, the Second Phase 3 Pivotal Study of Lemborexant
Sep 07, 2018
China Cyproconazole Export Analysis Report - ResearchAndMarkets.com
Sep 06, 2018
Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Montelukast Tablets USP, 10mg 30Ct. due to product/label mix-up
Sep 05, 2018
Exports of Lambda-Cyhalothrin from China: 2018 Analysis Report - ResearchAndMarkets.com
Jul 24, 2018
China Latanoprost Market Report 2018-2022
Jul 02, 2018
Eisai and Purdue Pharma Announce Oral Presentation of Latest Clinical and Non-Clinical Data on Lemborexant at 43rd Annual Meeting of the Japanese Society of Sleep Research